Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-15-064255

← back to feed
Filed
Nov 12, 2015 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 10, 2015 23.56M sh
Short Term Debt Q3 2015 · Sep 30, 2015 $250K
Short Term Debt Q3 2015 · Dec 31, 2014 $200K
Cash And Equivalents Q3 2015 · Sep 30, 2015 $61.27K
Cash And Equivalents Q3 2015 · Dec 31, 2014 $12.51K
Cash And Equivalents Q3 2015 · Sep 30, 2014 $75.63K
Cash And Equivalents Q3 2015 · Dec 31, 2013 $44.9K
Stockholders Equity Q3 2015 · Sep 30, 2015 −$6.59M
Stockholders Equity Q3 2015 · Dec 31, 2014 −$5.66M
Current Liabilities Q3 2015 · Sep 30, 2015 $5.95M
Current Liabilities Q3 2015 · Dec 31, 2014 $4.98M
Total Liabilities Q3 2015 · Sep 30, 2015 $6.65M
Total Liabilities Q3 2015 · Dec 31, 2014 $5.68M
Current Assets Q3 2015 · Sep 30, 2015 $61.27K
Current Assets Q3 2015 · Dec 31, 2014 $12.51K
Total Assets Q3 2015 · Sep 30, 2015 $61.27K
Total Assets Q3 2015 · Dec 31, 2014 $12.51K
Sga Expense Q3 2015 · Sep 30, 2015 $156.21K
Sga Expense Q3 2015 · Sep 30, 2015 $1.2M
Sga Expense Q3 2015 · Sep 30, 2014 $161.63K
Sga Expense Q3 2015 · Sep 30, 2014 $419.42K
Rd Expense Q3 2015 · Sep 30, 2015 $161.19K
Rd Expense Q3 2015 · Sep 30, 2015 $483.17K
Rd Expense Q3 2015 · Sep 30, 2014 $125.12K
Rd Expense Q3 2015 · Sep 30, 2014 $400.43K
Net Income Q3 2015 · Sep 30, 2015 −$326.1K
Net Income Q3 2015 · Sep 30, 2015 −$1.7M
Net Income Q3 2015 · Sep 30, 2014 $226.85K
Net Income Q3 2015 · Sep 30, 2014 −$973.44K
Operating Income Q3 2015 · Sep 30, 2015 −$317.4K
Operating Income Q3 2015 · Sep 30, 2015 −$1.68M
Operating Income Q3 2015 · Sep 30, 2014 −$286.75K
Operating Income Q3 2015 · Sep 30, 2014 −$819.84K
Revenue Q3 2015 · Sep 30, 2015 $0
Revenue Q3 2015 · Sep 30, 2015 $0
Revenue Q3 2015 · Sep 30, 2014 $0
Revenue Q3 2015 · Sep 30, 2014 $0